Skip to main navigation Skip to search Skip to main content

Kynurenine-3-monooxygenase (KMO) inhibition as a novel therapeutic strategy to enhance islet cell viability and improve outcomes of Islet Cell Transplantation

Project Details

StatusActive
Effective start/end date1/12/21 → 30/06/26

Funding

  • Medical Research Council: £340,706.00